Eye Drops After Cataract Surgery: Key Facts for Recovery

Most people who have cataract surgery will go home with prescriptions for two or three different eye drops, each targeting a distinct threat to the healing eye. The standard regimen typically includes an antibiotic to prevent infection, a corticosteroid to control inflammation, and a nonsteroidal anti-inflammatory drug (NSAID) to reduce the risk of swelling at the back of the eye. Getting these drops right matters more than many patients expect, and the practical challenges of juggling multiple bottles on a strict schedule trip up a surprisingly large number of people.

The Three Categories of Drops and What Each One Does

A typical post-cataract drop regimen combines three medications, sometimes prescribed as separate bottles and sometimes compounded into a single formulation. One common combination studied in clinical trials pairs prednisolone acetate (a steroid), gatifloxacin (an antibiotic), and bromfenac (an NSAID) into a single drop, though many surgeons still prescribe each medication individually.¹ Understanding why you need all three, rather than just one, helps make the post-surgical schedule feel less arbitrary.

The antibiotic drop is the shortest course, usually lasting about a week. Its job is to keep bacteria from entering the eye through the tiny incision made during surgery. The steroid drop runs longer, often four to six weeks, and gets tapered gradually to prevent a rebound of inflammation inside the eye. The NSAID drop also continues for several weeks and serves a somewhat different anti-inflammatory role, specifically targeting a type of swelling called macular edema that can blur your central vision even after a technically perfect surgery.

How Antibiotics Guard Against Infection

Endophthalmitis, a serious infection inside the eye, is the nightmare complication every cataract surgeon works to prevent. The good news is that it is exceptionally rare, occurring in roughly 0.006 to 0.04 percent of cataract surgeries.² The bad news is that when it does happen, it can cause severe and permanent vision loss. That combination of low probability and high severity is exactly why nearly all patients end up on antibiotic drops even though few randomized controlled trials have definitively proven that the postoperative drops alone prevent infection.

The strongest evidence for antibiotics actually comes from injections given during the surgery itself rather than from the drops you take home. A large Cochrane review found that injecting an antibiotic directly into the eye at the time of surgery reduced endophthalmitis risk substantially, and that combining this injection with topical antibiotic drops cut risk even further compared to drops alone.³ By contrast, topical antibiotic drops used without an intraoperative injection showed an uncertain effect on preventing endophthalmitis in that same review. One study from Scandinavia went further and found no difference in infection rates when comparing patients who received postoperative antibiotic-steroid drops against those who received steroid drops alone.⁴

So why do surgeons still prescribe them? Because the drugs are low-risk, the infection they guard against is devastating, and dropping a week of antibiotic drops feels like cheap insurance even if the marginal benefit on top of intraoperative antibiotics is uncertain. This is one of those areas where clinical practice runs ahead of the evidence rather than behind it.

Why NSAIDs Matter for Your Central Vision

Pseudophakic cystoid macular edema, often just called macular edema after cataract surgery, is a buildup of fluid in the macula, the part of the retina responsible for sharp, detailed vision. It can develop weeks after an otherwise uneventful surgery and is one of the more common reasons people notice their vision plateauing or even worsening during recovery.

NSAID eye drops have consistently shown they reduce this risk. A Cochrane systematic review covering thousands of eyes found that topical NSAIDs cut the likelihood of macular edema roughly in half compared to placebo or no treatment, though the reviewers cautioned that the true size of the benefit might be somewhat exaggerated by the way the studies were designed.⁵ In head-to-head comparisons against steroid drops alone, NSAIDs came out clearly ahead for preventing macular edema. One systematic review found that the prevalence of macular edema was about 3.8 percent in patients using NSAIDs compared to more than 25 percent in those using steroids alone.⁶

That gap explains why most surgeons prescribe both a steroid and an NSAID rather than choosing one or the other. The steroid handles the broader inflammatory response inside the eye, while the NSAID specifically targets the prostaglandin-driven swelling that leads to macular edema. Among the NSAID options, network meta-analyses comparing different formulations have found that bromfenac and nepafenac perform similarly in preventing foveal thickening, with some evidence that higher-concentration nepafenac may have a slight edge in keeping the macula thin and that bromfenac may offer a small advantage in visual acuity at one month.⁷ In practice, your surgeon picks the NSAID they are most familiar with, and the differences between brands are small enough that you should not worry about which one you were prescribed.

Steroid Side Effects and the Pressure Question

Corticosteroid eye drops do the heavy lifting against inflammation, but they come with a well-known catch: they can raise pressure inside the eye. This steroid-induced rise in intraocular pressure (IOP) is the main drawback of topical steroid therapy after cataract surgery and, in susceptible people, can lead to steroid-induced glaucoma if left unchecked.⁸

Most steroid responders develop elevated pressure during the first few weeks of using the drops, which is one reason surgeons schedule follow-up visits within that window. In rare cases, though, the pressure spike can happen almost immediately. One documented case showed high IOP at the very first morning visit after surgery, which is unusual because steroid response is not generally considered a cause of elevated pressure that soon. The patient’s pressure normalized once the steroid drops were stopped.⁹

Not all steroid drops carry the same risk. Studies comparing prednisolone acetate and difluprednate, two of the most commonly prescribed options, have found that both can push IOP above normal thresholds in a small percentage of eyes within the first month.¹⁰ Some surgeons opt for lower-potency steroids like loteprednol or fluorometholone in patients who are known steroid responders or who have glaucoma. If you have a history of elevated eye pressure, make sure your surgeon knows before the drop regimen is finalized. Your follow-up visits will include pressure checks, and the steroid taper can be accelerated if your IOP starts climbing.

Why So Many People Use the Drops Wrong

Here is something that does not get talked about enough: the vast majority of patients do not administer their eye drops correctly. A study evaluating inexperienced patients after cataract surgery found that more than nine out of ten showed improper technique when observed objectively. About a third missed the eye entirely on at least one attempt, nearly two-thirds instilled the wrong number of drops, and more than half contaminated the bottle tip by touching it to the eye or eyelid.¹¹ Close to eight in ten did not wash their hands before instilling drops.

The same study found that patients who had received specific instructions on drop technique were far more likely to do it properly, with about twelve times the odds of a good performance score compared to those left to figure it out on their own. That finding underlines a real gap in the surgical process: many clinics spend extensive time on informed consent and pre-operative preparation but allocate only a few seconds to demonstrating how to actually use the drops that the entire recovery depends on.

A few practical tips that help:

• Wash hands first: soap and water before every session, even if it feels excessive.
• Tilt and pull: tilt your head back, pull the lower lid down to form a small pocket, and aim the drop into that pocket rather than directly onto the eyeball.
• Wait between drops: if you are using more than one medication, wait at least five minutes between different drops so each one has time to absorb rather than washing the previous one out.
• Close gently: close your eye for a minute or two after instilling the drop, or press lightly on the inner corner of your eye near the nose, to keep the medication in contact with the eye rather than draining into your tear duct.
• Avoid the tip: hold the bottle about an inch above the eye and do not let the tip touch anything, including your eyelashes.

Education level can also play a role. A study from Ghana found statistically significant differences in how often patients forgot to administer drops or forgot to wash their hands, with higher education associated with fewer lapses.¹² This does not mean less-educated patients cannot manage their drops. It means the system should provide better support, like pictorial guides, caregiver training, and hands-on demonstration, rather than relying on written instructions that not everyone can easily follow.

Preservatives and Their Effect on the Eye’s Surface

Most multi-dose eye drop bottles contain preservatives to prevent bacterial contamination, and benzalkonium chloride (BAK) is by far the most common one. BAK is effective at keeping the bottle sterile, but it is also toxic to the cells on the surface of the cornea, and after cataract surgery, when you are using multiple drops several times a day, the cumulative exposure adds up quickly.

Case reports have documented corneal toxicity from BAK in the post-cataract setting, with symptoms including corneal folds and superficial erosions of the corneal surface. In reported cases, the corneal problems improved once BAK-containing drops were either removed from the regimen or switched to preservative-free formulations.¹³

This is worth knowing because dry eye and surface irritation after cataract surgery are extremely common. The prevalence of dry eye symptoms following cataract surgery has been reported as high as roughly 56 percent.¹⁴ Some of that comes from the surgery itself, which disrupts corneal nerves and the tear film. But preservative exposure from weeks of multi-drop regimens can make things worse. If you are experiencing persistent burning, grittiness, or redness that feels disproportionate to how your recovery is going otherwise, ask your surgeon whether a switch to preservative-free formulations is possible. Not all medications come in preservative-free versions, but some do, and artificial tears used to supplement comfort are widely available without preservatives.

Dropless and Less-Drop Alternatives

The challenges of drop compliance, cost, and preservative toxicity have pushed many surgeons toward “dropless” or “less-drop” cataract surgery, where medications are delivered by injection during the procedure itself rather than through weeks of topical drops.

In a dropless approach, the surgeon typically injects a long-acting steroid, such as triamcinolone, beneath the tissue covering the eye (sub-Tenon’s space) and an antibiotic, such as moxifloxacin, directly into the eye at the end of surgery.² Another technique involves injecting a combination of steroid and antibiotic through the zonules into the vitreous cavity. Studies comparing these injection-based approaches to standard drop regimens have generally found comparable outcomes in terms of inflammation control, macular thickness, pressure, and pain levels. In one study, patients who received the injection significantly preferred the overall experience compared to those using drops.¹⁵

Dropless surgery also has potential cost advantages for the healthcare system. Researchers have investigated whether eliminating weeks of topical prescriptions could reduce both out-of-pocket costs for patients and overall spending.¹⁶ That matters because the financial burden of postoperative eye drops is not trivial. In a large analysis of Medicare beneficiaries who had cataract surgery in 2016, postoperative drops were prescribed to 88 percent of patients, with brand-name medications making up more than half of all prescriptions. The total cost exceeded $167 million, and the researchers estimated that switching to therapeutic and generic alternatives could have saved as much as $118 million, or about 70 percent of the total spending.¹⁶

Dropless surgery is not universally available. Not every surgeon offers it, and some patients, particularly those with complicated cataracts or coexisting eye conditions, may still need supplemental topical drops even after an injection-based approach. But the trend is moving in this direction, and if the idea of juggling multiple bottles for weeks sounds daunting, it is worth asking your surgeon whether a dropless or less-drop option is available for your case.

Warning Signs That Need Prompt Attention

Most cataract surgeries go smoothly, and the drops do their job without drama. But complications, while uncommon, can develop during the recovery window. Endophthalmitis, the most dangerous infection, typically presents with increasing pain, worsening redness, and sometimes a purulent discharge, all accompanied by decreasing vision.¹⁷ These symptoms usually appear within the first week after surgery, though delayed-onset infections can show up weeks or even months later.

Steroid-related pressure spikes are usually caught at follow-up visits, but if you start having headaches, a deep ache behind the eye, or notice halos around lights between appointments, call your surgeon’s office. A sudden increase in floaters, flashing lights, or a curtain-like shadow in your peripheral vision could signal a retinal issue and warrants same-day evaluation.

It is normal to have mild redness, mild light sensitivity, and a gritty or scratchy feeling during the first week or two. What is not normal is a progressive worsening of any symptom after the first few days. The general rule is that things should be slowly and steadily getting better. If they are getting worse, even if you cannot pinpoint exactly what has changed, pick up the phone. Early intervention for complications like endophthalmitis dramatically improves outcomes, and a false alarm is always preferable to a delayed one.

The Cost Problem With Postoperative Drops

Eye drops after cataract surgery are deceptively expensive. For an older adult on a fixed income, spending more than $200 on drops for a single eye’s recovery is a real burden. Many patients do not learn the cost until they arrive at the pharmacy, which can lead to sticker shock, delayed pickups, or skipped doses. Insurance coverage varies widely: some Medicare plans cover generics well but leave patients paying most of the cost for brand-name formulations, while others cover little of either.

The tendency to prescribe brand-name drops when effective generics exist has driven much of the excess spending. Generic prednisolone, generic NSAID drops, and generic fluoroquinolone antibiotics can accomplish the same clinical goals at a fraction of the price. If your surgeon’s office hands you a prescription and the pharmacy rings it up at a number that gives you pause, ask whether a generic substitution is available. In many cases it is, and the only reason you received a brand-name prescription is habit or pharmacy default, not a clinical necessity.

Compounded combination drops, which bundle the steroid, antibiotic, and NSAID into a single bottle, represent another cost-saving approach. These reduce the number of bottles from three to one, simplify the dosing schedule, and often come in at a lower total price than three separate brand-name prescriptions. Not all pharmacies compound them, and availability depends on your location, but specialty compounding pharmacies can often ship them directly to you. Ask your surgeon’s office whether this is an option before filling three separate prescriptions.